You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 10,195,183


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,195,183
Title:Compositions and methods for treating chronic urticaria
Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of mast cells, basophils, eosinophils, or a combination thereof, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
Inventor(s): Bozik; Michael E (Pittsburgh, PA), Dworetzky; Steven (Pittsburgh, PA)
Assignee: Knopp Biosciences LLC (Pittsburgh, PA)
Application Number:15/675,912
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using United States Patent 10,195,183 as an Example

Introduction

When analyzing a U.S. patent, understanding the scope and claims is crucial for determining the patent's validity, enforceability, and potential impact on the market. This article will delve into the details of patent scope and claims using United States Patent 10,195,183 as a case study.

Understanding Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is defined by the claims of the patent, which are the legally binding descriptions of the invention[3].

Metrics for Measuring Patent Scope

Researchers often use metrics such as independent claim length and independent claim count to measure patent scope. These metrics can indicate the complexity and breadth of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

The Role of Patent Claims

Patent claims are the heart of a patent application, as they define the invention and the scope of protection sought. Here are some key aspects of patent claims:

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to an independent claim and further limit the scope of the invention[2].

Claim Language and Clarity

The language used in patent claims must be clear and specific to avoid ambiguity. Claims that are overly broad or vague can lead to issues during the examination process and may result in the patent being deemed invalid[3].

The Patent Examination Process

The patent examination process is critical in refining the scope of patent claims.

Steps in the Examination Process

  • Filing a Provisional Patent Application: This initial step allows inventors to file a provisional application, which gives them one year to decide whether to proceed with a non-provisional application[2].
  • Filing a Non-Provisional Patent Application: If the inventor decides to proceed, a non-provisional application is filed, which begins the formal examination process.
  • Patent Examiner Review: The patent examiner reviews the application to determine if the invention is novel, useful, and nonobvious. This process can take several years and may involve multiple rounds of arguments and amended claims[2].

Narrowing Claims During Examination

The examination process often results in the narrowing of patent claims. This is because examiners may challenge the breadth of the claims, leading to revisions that make the claims more specific and less broad[3].

Tools and Resources for Patent Search and Analysis

Several tools and resources are available for searching and analyzing patents:

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and analyzing patent claims. It provides enhanced access to prior art and allows users to view and download bibliographic data[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices. This helps in identifying the patent family and related applications, as well as accessing citation data and office actions[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP Offices, enabling users to visualize search results for the same invention on a single page. This is particularly useful for analyzing the prior art cited by different offices[1].

Case Study: United States Patent 10,195,183

To illustrate the concepts discussed, let's consider United States Patent 10,195,183.

Patent Title and Abstract

The title and abstract provide a general overview of the invention. For example, if the patent is titled "Method and System for [Specific Invention]," the abstract would briefly describe the method and system.

Claims Analysis

  • Independent Claims: Analyze the independent claims to understand the core of the invention. These claims should be broad enough to cover the essential features of the invention but not so broad as to be invalid.
  • Dependent Claims: Review the dependent claims to see how they further limit the scope of the independent claims.

Prior Art and Citation Analysis

Use tools like the Common Citation Document (CCD) to analyze the prior art cited by different offices. This helps in understanding how the patent office viewed the novelty and nonobviousness of the invention.

Examination History

Review the examination history using the Patent Examination Data System (PEDS) or the Global Dossier. This can provide insights into how the claims were narrowed during the examination process and any challenges faced by the inventor[1].

Key Takeaways

  • Patent Scope: Defined by the claims, patent scope is crucial for determining the breadth and depth of protection.
  • Claim Language: Clear and specific language is essential for valid and enforceable claims.
  • Examination Process: The examination process often narrows claims, making them more specific.
  • Tools and Resources: Utilize tools like USPTO Patent Public Search, Global Dossier, and CCD for comprehensive patent analysis.

FAQs

What is the purpose of independent claims in a patent application?

Independent claims define the invention without reference to other claims and are the broadest claims in the patent application.

How does the patent examination process affect patent claims?

The examination process often results in the narrowing of patent claims as examiners challenge the breadth of the claims, leading to more specific and less broad claims.

What is the Common Citation Document (CCD) and how is it used?

The CCD consolidates citation data from participating IP Offices, enabling users to visualize search results for the same invention on a single page, which is useful for analyzing prior art.

What are the key metrics for measuring patent scope?

Key metrics include independent claim length and independent claim count, which can indicate the complexity and breadth of the patent claims.

Why is it important to analyze the examination history of a patent?

Analyzing the examination history provides insights into how the claims were narrowed and any challenges faced by the inventor, which can be crucial for understanding the patent's validity and enforceability.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. KU Office of Research - Intellectual Property Protection: https://research.ku.edu/intellectual-property-protection
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Harvard Business School - Patent search: A comparative table of databases: https://asklib.library.hbs.edu/faq/266950

More… ↓

⤷  Subscribe

Details for Patent 10,195,183

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 August 24, 1998 10,195,183 2033-08-13
Immunex Corporation ENBREL etanercept For Injection 103795 November 02, 1998 10,195,183 2033-08-13
Immunex Corporation ENBREL etanercept For Injection 103795 May 27, 1999 10,195,183 2033-08-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.